logo

BIAF

bioAffinity·NASDAQ
--
--(--)
--
--(--)

BIAF fundamentals

bioAffinity (BIAF) released its earnings on Aug 14, 2025: revenue was 1.27M (YoY -47.05%), missed estimates; EPS was -5.1 (YoY +10.53%), missed estimates.
Revenue / YoY
1.27M
-47.05%
EPS / YoY
-5.1
+10.53%
Report date
Aug 14, 2025
EPS
Q3,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-35.1-5.4-6-7.8-8.1-6.3-5.7-4.8-5.7-4.8-5.1
Forecast
-6.3-3.9-5.4-6-5.7-5.1-4.5-4.2-4.8-3
Surprise
0.00%
+14.29%
-53.85%
-44.44%
-35.00%
-10.53%
-11.76%
-6.67%
-35.71%
0.00%
-70.00%
Revenue
Q3,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
0921.00K19.74K298.48K2.20M2.41M2.40M2.35M2.20M1.85M1.27M
Forecast
--100.00K0100.00K1.80M2.00M2.45M2.54M2.42M2.11M1.51M
Surprise
0.00%
+821.00%
0.00%
+198.48%
+22.22%
+20.32%
-2.18%
-7.43%
-8.93%
-12.11%
-15.70%

Earnings Call